-
Mashup Score: 0
Nestlé announced Monday the divestment of its peanut allergy treatment business Palforzia (peanut allergen powder-dnfp) to Stallergenes Greer for an undisclosed sum. Nestlé kicked off…
Source: ml.firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
— Despite uncertainty regarding longer-term outcomes, lovo-cel and exa-cel both estimated to produce substantial gains in length and qualit…
Source: ml.firstwordpharma.comCategories: Latest Headlines, Rare DiseaseTweet
https://t.co/4r8LGwAPQ4